BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 17851245)

  • 1. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
    San L; Arranz B; Martinez-Raga J
    Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
    Green AI
    J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
    Green AI
    J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance abuse in schizophrenia: a review.
    Buckley PF
    J Clin Psychiatry; 1998; 59 Suppl 3():26-30. PubMed ID: 9541335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
    Horsfall J; Cleary M; Hunt GE; Walter G
    Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of comorbid bipolar disorder and substance abuse.
    Vornik LA; Brown ES
    J Clin Psychiatry; 2006; 67 Suppl 7():24-30. PubMed ID: 16961421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of clozapine on aggression and substance abuse in schizophrenic patients.
    Volavka J
    J Clin Psychiatry; 1999; 60 Suppl 12():43-6. PubMed ID: 10372611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dual diagnosis in psychiatric inpatients: prevalence and general characteristics].
    Rodríguez-Jiménez R; Aragüés M; Jiménez-Arriero MA; Ponce G; Muñoz A; Bagney A; Hoenicka J; Palomo T
    Invest Clin; 2008 Jun; 49(2):195-205. PubMed ID: 18717266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of schizophrenia and comorbid substance use disorder. A systematic review].
    Wobrock T; D'Amelio R; Falkai P
    Nervenarzt; 2008 Jan; 79(1):17-8, 20-2, 24-6 passim. PubMed ID: 17619840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies.
    Baker A; Bucci S; Lewin TJ; Richmond R; Carr VJ
    Psychiatry Res; 2005 Apr; 134(3):241-50. PubMed ID: 15892983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
    Coulston CM; Perdices M; Tennant CC
    Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depression and comorbid substance use disorders.
    Davis L; Uezato A; Newell JM; Frazier E
    Curr Opin Psychiatry; 2008 Jan; 21(1):14-8. PubMed ID: 18281835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alcohol and cocaine abuse. A comparison of epidemiology and clinical characteristics.
    Closser MH; Kosten TR
    Recent Dev Alcohol; 1992; 10():115-28. PubMed ID: 1317046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
    Wheeler AJ
    Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual diagnosis in an inpatient drug-abuse detoxification unit.
    Nocon A; Bergé D; Astals M; Martín-Santos R; Torrens M
    Eur Addict Res; 2007; 13(4):192-200. PubMed ID: 17851240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.